Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Eli Lilly 22.974, Pfizer 15.034.
Eli Lilly vs Pfizer: Revenue Comparison
Eli Lilly (LLY) and Pfizer (PFE) are peers in GLP-1. Eli Lilly reported revenue of $23.0B as of Q2 2026, compared with $15.0B for Pfizer. Eli Lilly leads on revenue.
Eli Lilly's gross margin is 85.8% versus 72.8% for Pfizer. Eli Lilly's net margin is 30.9% versus -1.6% for Pfizer.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Pfizer.| Metric | Eli Lilly | Pfizer |
|---|---|---|
| Market Cap | - | - |
| Revenue | $22.97B | $15.03B |
| Cost of Revenue | $3.27B | $4.09B |
| Gross Profit | $19.71B | $10.94B |
| Operating Income | $8.98B | $4.71B |
| Net Income | $7.09B | $-246.00M |
| R&D Expense | $3.82B | $2.81B |
| Earnings Per Share | $7.94 | -$0.04 |
| Gross Margin | 85.8% | 72.8% |
| Operating Margin | 39.1% | 31.3% |
| Net Profit Margin | 30.9% | -1.6% |
| Free Cash Flow | $7.76B | $302.00M |
| Cumulative Free Cash Flow | $109.66B | $356.70B |
| Operating Cash Flow | $10.69B | $835.00M |
| Cash & Equivalents | $8.89B | $976.00M |